Premium
BCL2 mRNA or protein abundance is superior to gene rearrangement status in predicting clinical outcomes in patients with diffuse large B ‐cell lymphoma
Author(s) -
Li Y.,
Tyryshkin K.,
Good D.,
Farmer P.,
Scott D.W.,
Crocker S.,
Baetz T.,
LeBrun D.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2439_17
Subject(s) - fluorescence in situ hybridization , immunohistochemistry , messenger rna , biopsy , biology , microbiology and biotechnology , pathology , in situ hybridization , diffuse large b cell lymphoma , lymphoma , gene expression , gene , medicine , immunology , genetics , chromosome